PWPuspita Eka Wuyung

Puspita Eka Wuyung

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Puspita Eka Wuyung has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Protective Effects of 5-MTP in a Rat Model of Diabetic Cardiomyopathy Through Anti-Inflammatory, Anti-Apoptotic, and Antifibrotic Mechanisms

    by Susetyo Atmojo, Bambang Budi Siswanto, Nurjati Chairani Siregar, Aria Kekalih, Fadlina Chany Saputri, Budi Susetyo Pikir, Deni Noviana, Apridya Nurhafizah, Wilbert Huang, Puspita Eka Wuyung

    Background: Diabetic cardiomyopathy (DCM) is characterized by myocardial inflammation, apoptosis, and fibrosis that contribute to ventricular remodeling and dysfunction. We investigated the effects of 5-methoxytryptophan (5-MTP) on histopathological and molecular markers of myocardial remodeling in a rat model of DCM. Methods: Forty-eight Sprague–Dawley rats with DCM induced by a high-fat high-fructose diet and low-dose streptozotocin (25 mg/kg) were randomized to control or 5-MTP treatment (25, 50, or 100 mg/kg) and evaluated after 8, 16, and 32 days. Histopathological assessment using hematoxylin–eosin and Masson’s trichrome staining, along with immunohistochemical analysis of inflammatory, apoptotic, and fibrotic markers, was performed. Results: Myocardial inflammatory histopathological scores did not differ significantly among groups. Myocardial fibrosis assessed by Masson’s trichrome staining was significantly reduced at day 16 (p = 0.020), with all 5-MTP doses demonstrating lower fibrosis scores than DCM controls. Collagen I expression did not differ significantly. Caspase-3 expression was significantly reduced in all treatment groups at day 16 (p = 0.029), with persistent reduction at day 32 only in the 100 mg/kg group (p = 0.004). Early molecular modulation was observed through reduced TGF-β expression at day 8 in the 25 mg/kg and 50 mg/kg groups, followed by reduced SMAD3 expression at day 16 in the 25 mg/kg and 100 mg/kg groups. At day 16, AKT expression increased in the 25 mg/kg group, while cytoplasmic NF-κB expression decreased in the 25 mg/kg and 100 mg/kg groups. Conclusion: 5-MTP demonstrated time-dependent changes in molecular and histopathological markers associated with myocardial remodeling in experimental DCM.

  • Open Access

    Moringa oleifera Leaf Extract Improves Cognitive Function in Rat Offspring Born to Protein-Deficient Mothers

    by Norma Tiku Kambuno, Achmad Gigih Andy Putra, Melva Louisa, Puspita Eka Wuyung, Ina Susianti Timan, Otto Sahat Martua Silaen, Heri Ahmad Sukria, Taniawati Supali

    Background: Malnutrition during pregnancy and the first 1000 days of life can impair brain function and hippocampus development. Research has shown that protein deficiency (PD) in pregnant and lactating mothers can lead to neurocognitive issues from early life into adulthood. Moringa oleifera has been used as a dietary supplement for malnutrition; however, its neuroprotective effects on offspring with PD are unclear. Aims: This study aimed to investigate the effects of ethanol leaf extract of Moringa oleifera (EEMO) on rat offspring born to mothers who experienced protein deficiency during pregnancy and lactation. Methods: Female Sprague Dawley rats were given low (9% protein) or normal protein diets (18% protein) during pregnancy and lactation. Afterward, EEMO was administered to the offspring starting from the end of lactation for 5 weeks. Results: Offspring from mothers with protein deficiency showed low birth weight, slow weight gain, low BMI, low albumin levels, and anemia compared to those born with mothers fed with a standard protein diet. However, pups treated with EEMO showed higher cognitive improvement and a decrease in the ratio of abnormal to normal cells in the cornu ammoni (CA) CA1, CA2, CA3, and CA4 regions of the hippocampus. Conclusions: The present study suggests that EEMO supplementation could improve conditions of protein deficiency and cognitive function, making it a cost-effective dietary supplement for addressing these issues.